The main office of represented VC is situated in the Zug. The company was established in Europe in Switzerland.
Among the most popular portfolio startups of the fund, we may highlight ARMO BioSciences, Harmony Biosciences, Vivoryon Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Medical Device. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
Besides them, we counted 4 critical employees of this fund in our database.
The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. The typical startup value when the investment from HBM Healthcare Investments AG is 100-500 millions dollars. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this HBM Healthcare Investments AG performs on 3 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the HBM Healthcare Investments AG, startups are often financed by OrbiMed, Kleiner Perkins, Novo Holdings. The meaningful sponsors for the fund in investment in the same round are OUP (Osage University Partners), Novartis Venture Fund, Venrock. In the next rounds fund is usually obtained by SV Health Investors, Alta Partners, Maverick Ventures.
|200M||26 May 2021||United States, Wilmington|
|152M||30 Mar 2021||United States, Boston|
|95M||12 Mar 2021|
|114M||10 Mar 2021||United States, Encinitas|
|125M||02 Mar 2021||United States, Cambridge|
|149M||13 Jan 2021||Denmark, Copenhagen|
|107M||11 Jan 2021||United States, Cambridge|
|150M||08 Jan 2021||China, Shanghai|
|72M||07 Jan 2021||United States, Cambridge|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.